Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis

Clinical trial NCT01719159 · COMPLETED

Trial details

NCT number: NCT01719159
Sponsor: Anders Svenningsson
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Progressive Multiple Sclerosis

Start date: 2009-11-01
Primary completion: 2016-06-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.